Replies to post #91022 on Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

One important thing to consider is that ABSSSI is simply the shortest path to market for Brilacidin. If you have time go back through my posts about 60 days. They are not nearly as informative as Slcimunno's posts but I try to include one or two slides at a time that shine a light on the potential of Brilacidin in particular. ABSSI is a gateway indication. Brilicidin also has anti-inflammatory properties. They already had a division of a large pharmacy wanting to use it on implants once approved. It appears to work very well on oral mucocitus and I am sure you know what the current SOC for that is.

Welcome to the board!

[F1ash]

If you click on the poster rather than the post you can scan just that person's post history. When you have time make sure to look at Slcimunno's they are very in depth.

[youssef]

Sam I m in Boston too , this is a real deal , I know the company in Beverly . This board is a real deal read and learn. It s a gem of the life time

[tduggan]

OK: I work in emergency departments where we see many many skin infections OF course there is an advantage of one time treatment. But the world of health care is increasingly cost driven, as we have seen with the deals for Hep C drugs with health plans. Let's say you a have MRSA lower leg cellulitis, and the total cost of Daptomycin will be much less when generic- health plans will ask you to make 3 visits instead of 1 visit if it suits them. How much will patient convenience and somewhat better efficacy count?

Sam,

thank you for getting back about this. A couple of things regarding relative costs:

1: Who will make the decision in regards to the value of non-resistance vs. cost of resistance and additional treatment/s? can you or any other doc here put an estimated dollar value on that? I think this is the elephant in the room in this discussion. Look into the FDA giving Brilacidin QIDP designation. There is a huge international concern about SUPERBUGS. This gives Brilacidin and inestimable lead over Dapto.

2: what is the cost breakdown of the situation you describe: MRSA lower leg cellulitis, leaving out the cost of the medication?

3: How frequent is the incidence of patient non-compliance? What's the dollar value of eliminating this?

My closest neighbor suffered what I believe is what you describe. He had MRSA and a lesion or sore on his shin. After hospitalization, he went three times a week to a wound clinic. The clinic cleaned the lesion and applied a fresh dressing. Ten months later, when the lesion finally healed, his total copay for all the various parts of the treatment was $3200.00. This was over and above what Medicare and his Carpenter's Union med insurance covered.

He would have happily paid a few thousand more if his doc explained to him that Brilacidin would or might give him more effective treatment. His vehicle cost alone for over 120 trips to the wound clinic is worth a few thousand. Fortunately for him he is retired and active and his daughter works at the local hospital and helps him keep track of all his appointments and medical issues.

As this issue of relative costs may keep recurring, I am very interested to hear from Sam or any other working docs or insurance people as to a good breakdown of all the costs, tangible and intangible.

Tom

[frrol]

Welcome p53. You're going to encounter some paranoia and conspiracy silliness on a messageboard, ignore it. Looking forward to your insights as a medical practitioner, we have a few here already.

Lots of information available on the Cellceutix website, check that out first. You should also do a search of "Cellceutix" SeekingAlpha; the articles there are helpful, and be sure to read the comments below the articles. With your medical training you should have no trouble assessing CTIX's 3 main compounds and their MOA's. I have many medical family members and they are invested in CTIX, I hope you find it as exciting an investment as they do.